Bone Growth Stimulator Market Size, Share, By Product (Bone Morphogenetic Proteins, Platelet-rich Plasma, Bone Growth Stimulation Device [Electrical Stimulation, and Ultrasonic Stimulation]), Application (Spinal Fusion Surgeries, Delayed Union & Non-unions, Orthopedic Trauma Surgeries, Fractures, Oral Surgeries, and Others), End-User (Hospitals, Special Orthopedic Clinics, Homecare Setting, and Ambulatory Surgical Centers) and Region - Trends, Analysis, and Forecast till 2035

• The bone growth stimulator market size is contemplated to enlarge at a valuation of USD 1.9 Billion, by 2035.
• In 2024, the valuation for bone growth stimulator market was USD 1.1 Billion.
• The market is growing at a CAGR 5.4%.

Bone growth stimulator is a medical device that used to promote the healing and growth of bones, after fractures, surgeries, and in cases where bone healing is delayed or impaired. These devices work by applying electric or magnetic field to stimulate the bone repair. These devices are primarily used for patients with fractures that are slow to heal or for those undergoing bone-related surgeries, such as spinal fusion surgeries. The electrical and mechanical bone growth stimulator, are responsible for the bone formation, and healing which enhances the activity of osteoblasts and improve blood flow to the injured area to promote healing process.

The rising incidence of bone diseases, such as osteoporosis, fractures, and arthritis, increasing demand for bone growth stimulator devices, the growing orthopedic surgeries including spinal fusion, and joint replacement, and increasing the demand for bone healing devices is expected to drive target market growth over the forecast period.

Moreover, Growing awareness about benefits of bone growth stimulators, rises the adoption of advanced devices, and improvement in healthcare infrastructure, ongoing research & development to improve customized treatments, and expanding applications to treat osteopenia and osteoporosis, is expected create  opportunities for bone growth stimulator market expansion.

Impact of Generative AI on Bone Growth Stimulator Market:

• Artificial Intelligence (AI) can assist in creating personalized bone growth stimulators, which are tailored using individual’s specific bone healing needs. AI algorithms can analyze patient’s medical history, bone density, and imaging to generate personalized treatment plans. By integration of AI driven data into healthcare, doctors could receive AI-driven insights that enhance the effectiveness of bone stimulator.

Key Drivers of Target Market:

Rising Prevalence of Orthopedic Disorder is predicted to Market Growth

The rising occurrence of orthopedic disorder, such as osteoporosis, sports related fractures, injuries, hip fractures, and others are increases the demand for bone growth stimulator devices. The prevalence of orthopedic disorders rises, there is also increase in number of orthopedic surgeries, such as joint replacement, spinal surgeries, and bone fracture repairs, need bone healing devices, and is expected to drive target market growth. Hip fractures leads to concern in orthopedic healthcare, and it is combined with the functional loss, thus the need of bone healing devices rises. Osteoporosis, leads to the fragility fractures, which is commonly related to the weakened bone in older individuals, resulting to drive bone growth stimulator market growth.

• For instance, according to data published by International Osteoporosis Foundation, in October 2024, globally up to 37 million fragility fractures occur annually, in individuals aged over 55, this is equivalent to 70 fractures every minute. Globally, one in three women and one in five men over age 50 will experience an osteoporosis-related fracture over their remaining lifetimes. More than 10 million hip fractures in people aged more than 55 were recorded in 2019. The number of hip fractures is projected to nearly twine between 2018 and 2050. For the hip fractures, mortality rates of up to 20-24% in the first year; and among survivors, profound loss of function with 40% unable to walk independently and 33% either totally dependent or in a nursing home in the year following a hip fracture.

Restraints:

Lack of Awareness and Education Disrupted Target Market Growth

Lack of widespread awareness, and education in patients and healthcare providers, about the bone healing devices, leads to the underutilization opportunities for effective treatment. Many patients are not aware about the effectiveness of bone growth stimulators, and healthcare providers are still stuck on traditional treatment resulting to limit target market growth.

• Counterbalance Statements: Manufacturers, healthcare institutions, and professional organizations are working on awareness campaigns to educate both patient and healthcare providers, about the benefits of bone growth stimulators. For healthcare providers, medical education program can be developed for orthopedic surgeons, and physical therapists, to educate latest advancement in bone healing technologies, resulting to drive target market.

Opportunities & Market Trends:

Innovation in Robotic-assisted Solution for Arthroplasty Procedures Fuels Market Expansion

Arthroplasty, is known for knee and hip surgeries, and improvement in arthroplasty technologies, will create significant opportunity for target market expansion. The increasing orthopedic disorders, especially hip fractures and knee regalement surgeries, rises the demand for advanced bone healing devices. Integration of robotic-assisted surgeries, such as Unicompartmental Knee Arthroplasty (UKA) and Total Knee Arthroplasty (TKA), help ensure that implant placement is accurate, optimizing joint function and increasing the longevity of implants. This system allows for minimally invasive techniques, by reducing recovery time, reduced risk of complication, and less postoperative pain, resulting to drive bone growth stimulator market growth.

• For instance, according to article published by National Library of medicine, in August 2023,

The bone growth stimulator is segmented into product, application, End-User, and region.

Product:

By product, bone growth stimulator are classified into bone morphogenetic proteins, platelet-rich plasma, and bone growth stimulation device. The target market is dominated by bone growth stimulation devices segment, as these devices are non-invasive and use electromagnetic field, ultrasound and pulsed electromagnetic field, to stimulate the bone healing. This devices are widely used in spinal fractures, joint replacements, and other orthopedic condition is expected to boost segment’s growth in bone growth stimulator market size.

Bone morphogenetic proteins is second dominant segment in bone growth stimulator market, as it is effective and widely used in surgical procedures, where bone grafting is required. The growing demand of bone morphogenetic proteins in spinal fusion surgeries and bone grafting, is anticipated to drive segment’s growth in target market.

Application:

On the basis of application, bone growth stimulator market is segmented into spinal fusion surgeries, delayed union & non-unions, orthopedic trauma surgeries, fractures, oral surgeries, and others. Spinal fusion surgeries segment has largest bone growth stimulator market share, as it is common degenerative disc disease and spinal fractures, which use stimulators to speed up recovery for post surgeries. Bone growth stimulator devices accelerate the fusion process and reduce the risk of complication, resulting to drive segment’s growth in bone growth stimulator market share.  

Delayed union & non-unions segment hold the second largest share in bone growth stimulator market. Bone growth stimulators are widely used to treat delayed unions and non-unions of fractures, particularly in areas such as the long bones, spine, and pelvis. The increasing prevalence of bone fractures, with growing number of trauma and accidents, rises the demand for bone growth stimulators in delayed union & non-union segment for this market.

End-User:

Based on end-user bone growth stimulator market is categorized into, hospitals, special orthopedic clinics, homecare setting, and ambulatory surgical centers. Hospitals segment hold the largest share in target market, as it is offer comprehensive care for patients with fractures, orthopedic surgeries, and other bone conditions. Hospitals are equipped with advanced diagnostic tools, experienced orthopedic specialists, and surgical teams, is projected to drive segment growth in target market size.

Region:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This region hold the largest bone growth stimulator market share due to presence of well-established healthcare facilities, advanced treatment options and adoption of innovative medical technologies. The rising incidence of orthopedic fractures, spinal injuries, and sports injuries, significantly contributes to the demand for bone growth stimulators resulting to region growth in target market share.

• U.S. Bone Growth Stimulator Market Insights:

In North America, the U.S. is the dominant country for the bone growth stimulator market. U.S. contains advanced healthcare system with cutting edge medical technologies, large population affected by osteoporosis, degenerative bone diseases, and other orthopedic conditions, presence of leading market players, and rapid approval & commercialization of new technologies, is anticipated to drive target market growth.

Asia Pacific: This region is expected to witness as the highest growth rate in target market. The rising preference for non-invasive therapies, and increasing fractures incidence, due to high trauma rates, and sedentary lifestyles is contributing to market growth. The growing adoption of advanced bone growth stimulators, is projected to region growth in bone growth stimulator market size. 

• Japan Bone Growth Stimulator Market Insights:

Japan is the leading country in the Asia Pacific region for bone growth stimulator market. Japan has the larger oldest population, high prevalence of osteoporosis and other bone diseases, can increased the demand for advanced bone growth stimulator devices. The rapid adoption of cutting-edge technologies, and continuous improvement of bone healing devices is estimated to growth of bone growth stimulator market size.

Europe: This region is experiencing significant continuous growth in bone growth stimulator market. The aging population, with large population over age of 65, increase g healthcare investments, rising awareness about advanced medical treatments, and growing adoption of advanced healthcare technologies, bone growth stimulators is projected to expansion of bone growth stimulator market share in Europe region.

• Germany Bone Growth Stimulator Market Insights:

The dominant country in Europe for the bone growth stimulator market is Germany. It contains most advanced healthcare system, with advanced medical treatments. High prevalence of osteoporosis, spinal disorders, and degenerative bone diseases, which rises the demand for bone healing treatments, and growing adoption of new technologies, is anticipated to drive target market growth.

Bone Growth Stimulator Market Report Scope:

Attribute	Details
Market Size 2025	USD 1.2 Billion
Projected Market Size 2035	USD 1.9 Billion
CAGR Growth Rate	5.4% (2025-2035)
Base year for estimation	2024
Forecast period	2025 – 2035
Market representation	Revenue in USD Billion & CAGR from 2025 to 2035
Regional scope	North America - U.S., and Canada Europe – Germany, U.K., France, Russia, Italy, Spain, Netherlands, and Rest of Europe Asia Pacific – China, India Japan, Australia Indonesia Malaysia, South Korea, and Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa – GCC, Israel South Africa, and Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segmentation:

By Product:

• Bone Morphogenetic Proteins
• Platelet-rich Plasma
• Bone Growth Stimulation Device
  • Electrical Stimulation
  • Ultrasonic Stimulation

By Application:

• Spinal Fusion Surgeries
• Delayed Union & Non-unions
• Orthopedic Trauma Surgeries
• Fractures
• Oral Surgeries
• Others

By End-User:

• Hospitals
• Special Orthopedic Clinics
• Homecare Settings
• Ambulatory Surgical Centers

 By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the bone growth stimulator market include, Orthofix US LLC, IGEA S.p.A., Enovis Corporation, and others. These key players are focusing on improving research and development technique, and advancement in bone healing devices. The growing focus to improve overall orthopedic patient outcomes, companies are making partnership, or collaboration, and acquire companies to develop robotic assisted technology is projected to drive target market size.

Bone Growth Stimulator Market Companies:

• Orthofix US LLC
• IGEA S.p.A.
• Zimmer Biomet
• Bioventus
• Terumo Corporation
• Medtronic
• Arthrex, Inc.
• Enovis Corporation
• Ossatec
• Johnson & Johnson Services, Inc.
• BTT Health GmbH
• IGEA
• Isto Biologics
• Smith & Nephew plc
• ITO Co., Ltd.

View an Additional List of Companies in the Bone Growth Stimulator Market

• In March 2025, Osteoboost Health received 6^th U.S. patent from United States Patent and Trademark Office (USPTO). This wearable device designed to treat osteopenia and improve bone health through targeted vibration therapy. This devices, the first and only FDA-approved, non-drug prescription treatment for low bone density. This device aimed to deliver mechanical stimulation to bones, which helped to prserve and improve bone density.
• In September 2024, Orthofix Medical Inc., presented new data supporting Pulsed Electromagnetic Field (PEMF) Stimulation for Lumbar Spine Fusion, in North American Spine Society Annual Meeting (NASS). During the NASS annual meeting, Orthofix is also highlighting a variety of new products including the full market launch of OsteoStrand Plus C, a 100% bone-derived graft. It was comprised of Demineralized Bone Matrix fibers and Accell Bone Matrix, which provide immediate release of growth factors.
• In June 2024, Johnson & Johnson MedTech launched VELYS Robotic-Assisted Solution in Unicompartmental Knee Arthroplasty (UKA). This platform got approval form FDA for the used in Total Knee Arthroplasty (TKA), which had cleared for use in 20 markets and utilized in over 55,000 procedures. This technology aimed to help surgeons with the information needed to help preserve the soft tissues, to retuning knee function.
• In April 2024, Xstim, Inc., received approval from FDA for Xstim Spinal fusion stimulator. This device aimed to promote bone healing after spinal fusion surgery. The Xstim device was designed to prioritize patient easy to use and wearability, which offered a noninvasive alternative for indicated cases. The availability of non-invasive bone growth stimulation options such as, Xstim provides patients with an invaluable advantage. Its sleek design ensured simple therapy management without the disturbance of downloading and managing extra apps.
• In May 2022, Orthofix Medical, Inc., received FDA approval for the AccelStim bone healing therapy Class III device. The AccelStim device aimed to provide a safe and effective nonsurgical treatment for indicated fresh fractures and for fractures that have not healed. The device designed to generate a Low-Intensity Pulsed Ultrasound (LIPUS) signal to stimulate the bone’s natural healing process to promote fracture healing.

Analyst View:

The bone growth stimulator market is driven by, rising orthopedic disorders, technological advancement and increasing number of non-invasive treatments. The increase in the development of non-invasive, portable, and personalized none growth stimulators, is augmented to drive target market growth. The regulatory agencies such as FDA, and EMA are continuously focusing on these devise for more accessible to healthcare providers and patients.

More Related Reports

Nerve Stimulators Market
Bone Graft Substitutes Market
Dental Membrane and Bone Graft Substitute market
Bone Growth Stimulator Market
Bone Marrow Aspirate Concentrate Market

Company Name	Hanger Inc.
Headquarter	Austin, Texas
CEO	Pete Stoy
Employee Count (2024)	5,000 employees